The effectiveness of mobile application for monitoring diabetes mellitus and hypertension in the adult and elderly population: systematic review and meta-analysis
- PMID: 37573312
- PMCID: PMC10423411
- DOI: 10.1186/s12913-023-09879-6
The effectiveness of mobile application for monitoring diabetes mellitus and hypertension in the adult and elderly population: systematic review and meta-analysis
Abstract
Context: Arterial Hypertension (AH) and Diabetes Mellitus (DM) are diseases that are getting worse all over the world. Linked to this advance, is the growing digital health market with numerous mobile health applications, which aim to help patients and professionals in the proper management of chronic diseases. The aim of this study was to analyze, through a systematic review and meta-analysis, the effectiveness of using mobile health applications in monitoring AH and/or DM in the adult and elderly population.
Methods: The systematic review and meta-analysis was carried out in accordance with the Preferred Reporting Items for Systematic Reviews and Metanalyses guidelines and involved searching five databases - Medline/PubMed, Embase, CINAHL, Virtual Library in Health and Cochrane Library. The review included randomized and cohort clinical trials testing the effects of the intervention on changing biochemical parameters and clinical efficacy in people treated for AH and/or DM. The quality of the selected studies was assessed based on the evaluation criteria of the Joanna Briggs Institute tool. The random effects meta-analysis method was used to explain effect distribution between studies, by Stata® software (version 11.0) and publication bias was examined by visual inspection of graphs and Egger test.
Results: We included 26 studies in the systematic review and 17 in the meta-analysis. These studies were published between 2014 to 2022 in 14 countries. Were reported improvement in knowledge and self-management of AH and DM, social motivation with treatment and behavioral change, reduction in glycated hemoglobin values, fasting glucose and blood pressure, improvement in adherence to drug treatment, among others. The result of the meta-analysis showed that there is evidence that the use of mobile applications can help reduce glycated hemoglobin by 0.39% compared to the usual care group.
Conclusions: Monitoring and self-monitoring of behaviors and health care related to AH and DM in adults and the elderly through mobile applications, has clinically significant effectiveness in reducing glycated hemoglobin levels. Future studies should provide more evidence and recommendations for best practices and development of digital health interventions.
Trial registration: PROSPERO. International Prospective Registry of Systematic Reviews. CRD42022361928.
Keywords: Adult; Aged; Diabetes mellitus; Digital health; Hypertension; Mobile application; Systematic review.
© 2023. BioMed Central Ltd., part of Springer Nature.
Conflict of interest statement
The authors declare no competing interests.
Figures




Similar articles
-
Mobile solution and chronic diseases: development and implementation of a mobile application and digital platform for collecting, analyzing data, monitoring and managing health care.BMC Health Serv Res. 2024 Aug 31;24(1):1009. doi: 10.1186/s12913-024-11505-y. BMC Health Serv Res. 2024. PMID: 39217352 Free PMC article.
-
Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review.Health Technol Assess. 2020 Jun;24(28):1-232. doi: 10.3310/hta24280. Health Technol Assess. 2020. PMID: 32568666 Free PMC article.
-
A mobile health application use among diabetes mellitus patients: a systematic review and meta-analysis.Front Endocrinol (Lausanne). 2024 Oct 11;15:1481410. doi: 10.3389/fendo.2024.1481410. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39464188 Free PMC article.
-
The future of Cochrane Neonatal.Early Hum Dev. 2020 Nov;150:105191. doi: 10.1016/j.earlhumdev.2020.105191. Epub 2020 Sep 12. Early Hum Dev. 2020. PMID: 33036834
-
Effectiveness of Mobile App-Assisted Self-Care Interventions for Improving Patient Outcomes in Type 2 Diabetes and/or Hypertension: Systematic Review and Meta-Analysis of Randomized Controlled Trials.JMIR Mhealth Uhealth. 2020 Aug 4;8(8):e15779. doi: 10.2196/15779. JMIR Mhealth Uhealth. 2020. PMID: 32459654 Free PMC article.
Cited by
-
Enhancing tuberculosis treatment support: A thematic analysis of interactive messages in a digital adherence technology trial to identify needs, challenges, and strategies for improvement.PLoS One. 2025 Jul 24;20(7):e0326492. doi: 10.1371/journal.pone.0326492. eCollection 2025. PLoS One. 2025. PMID: 40705794 Free PMC article. Clinical Trial.
-
Metabolic Syndrome Indicators and Cardiovascular/Endocrine Risks in Rural Ecuador: A Cross-Sectional Study.J Pers Med. 2025 Feb 20;15(3):78. doi: 10.3390/jpm15030078. J Pers Med. 2025. PMID: 40137394 Free PMC article.
-
Assessing intention to use mobile phone-based self-management support among adults with type 2 diabetes in Saudi Arabia: A cross-sectional study.Digit Health. 2025 Jan 10;11:20552076241308993. doi: 10.1177/20552076241308993. eCollection 2025 Jan-Dec. Digit Health. 2025. PMID: 39801586 Free PMC article.
-
Impact of digital health on Type 2 diabetes management: a randomised controlled trial of the 'TreC Diabete' platform (TELEMECHRON Study).Front Clin Diabetes Healthc. 2025 Jun 10;6:1589548. doi: 10.3389/fcdhc.2025.1589548. eCollection 2025. Front Clin Diabetes Healthc. 2025. PMID: 40557310 Free PMC article.
-
Mobile solution and chronic diseases: development and implementation of a mobile application and digital platform for collecting, analyzing data, monitoring and managing health care.BMC Health Serv Res. 2024 Aug 31;24(1):1009. doi: 10.1186/s12913-024-11505-y. BMC Health Serv Res. 2024. PMID: 39217352 Free PMC article.
References
-
- NCD Risk Factor Collaboration (NCD-RisC) Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants. Lancet. 2021;398(10304):957–980. doi: 10.1016/S0140-6736(21)01330-1. - DOI - PMC - PubMed
-
- Hypertension. World Health Organization. 2021. https://www.who.int/health-topics/hypertension#tab=tab_1. [Accessed 2022–11–22].
-
- Saeedi P, Petersohn I, Salpea P, Malanda B, Karuranga S, Unwin N, Colagiuri S, Guariguata L, Motala AA, Ogurtsova K, Shaw JE, Bright D, Williams R, IDF Diabetes Atlas Committee Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: Results from the International Diabetes Federation Diabetes Atlas, 9th edition. Diabetes Res Clin Pract. 2019;157:107843. doi: 10.1016/j.diabres.2019.107843. - DOI - PubMed
-
- Diabetes. World Health Organization. 2021. https://www.paho.org/pt/noticias/11-11-2022-numero-pessoas-com-diabetes-.... [Accessed 2022–11–22].
-
- IDF - International Diabetes Federation. IDF Diabetes Atlas. 10ed. 2021. Availabre in: https://diabetesatlas.org/idfawp/resource-files/2021/07/IDF_Atlas_10th_E.... [Accessed 2023–05–28].
Publication types
MeSH terms
Substances
Grants and funding
- 306358/2020/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- 306358/2020/Conselho Nacional de Desenvolvimento Científico e Tecnológico
- APQ-02708-21/Fundação de Amparo à Pesquisa do Estado de Minas Gerais , Brasil
- APQ-02708-21/Fundação de Amparo à Pesquisa do Estado de Minas Gerais , Brasil
- APQ-02708-21/Fundação de Amparo à Pesquisa do Estado de Minas Gerais , Brasil
LinkOut - more resources
Full Text Sources
Medical